Essential (haemorrhagic) thrombocythaemia

primary myelofibrosis: Myelofibrosis with myeloid metaplasia is a myeloproliferative disease with annual incidence of approximately 1 case per 100,000 individuals and age at diagnosis around 60 (an increased prevalence is noted in Ashkenazi Jews). Clinical manifestations depend on the type of blood cell affected and may include anemia, pallor, splenomegaly, hypermetabolic state, petechiae, ecchymosis, bleeding, lymphadenopathy, hepatomegaly, portal hypertension.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries Inpat., Oupat., Death

Hospital Discharge: ICD-10 D47.3
Hospital discharge: ICD-9 2387B
Hospital discharge: ICD-8 2872
Cause of death: ICD-10 D47.3
Cause of death: ICD-9 2387B
Cause of death: ICD-8 2872

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector THROMBOCYTAEMIA

Extra metadata

First used in FinnGen datafreeze DF2, additional

Summary Statistics

Key figures

All Female Male
Number of individuals 479 293 186
Unadjusted prevalence (%) 0.18 0.20 0.16
Mean age at first event (years) 59.55 58.33 61.45

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.43 [0.68, 3.02] 3.5e-1 53
15 years 0.01 1.97 [0.98, 3.95] 5.8e-2 49
5 years 0.00 3.77 [2.02, 7.02] 3.0e-5 23
1 year - - - -

Correlations

Index endpoint: THROMBOCYTAEMIA – Essential (haemorrhagic) thrombocythaemia
GWS hits: 5

Survival analyses between endpoints

Plot

before Essential (haemorrhagic) thrombocythaemia
after Essential (haemorrhagic) thrombocythaemia

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Essential (haemorrhagic) thrombocythaemia